NAPOLI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 3.151
EU - Europa 2.402
AS - Asia 1.633
SA - Sud America 143
AF - Africa 43
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.395
Nazione #
US - Stati Uniti d'America 3.107
RU - Federazione Russa 778
PL - Polonia 636
SG - Singapore 489
CN - Cina 423
IT - Italia 322
HK - Hong Kong 233
IE - Irlanda 171
SE - Svezia 142
VN - Vietnam 134
KR - Corea 124
BR - Brasile 117
DE - Germania 90
FR - Francia 63
FI - Finlandia 62
IN - India 49
JO - Giordania 46
GB - Regno Unito 43
JP - Giappone 38
BD - Bangladesh 25
CA - Canada 22
AU - Australia 21
CH - Svizzera 18
MX - Messico 17
ES - Italia 16
TR - Turchia 16
BE - Belgio 14
ZA - Sudafrica 14
AR - Argentina 12
AT - Austria 11
ID - Indonesia 11
NL - Olanda 11
IQ - Iraq 10
NG - Nigeria 10
PK - Pakistan 7
UA - Ucraina 6
CI - Costa d'Avorio 5
MA - Marocco 5
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
BJ - Benin 3
CL - Cile 3
LT - Lituania 3
MY - Malesia 3
NO - Norvegia 3
OM - Oman 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
BG - Bulgaria 2
DK - Danimarca 2
EC - Ecuador 2
EG - Egitto 2
GR - Grecia 2
PH - Filippine 2
PY - Paraguay 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 7.395
Città #
Santa Clara 768
Warsaw 633
Ashburn 400
Singapore 349
Hong Kong 187
Chandler 176
Dublin 171
Fairfield 163
San Jose 138
Seoul 124
Cambridge 95
Beijing 91
Hefei 90
Ann Arbor 83
Seattle 82
Houston 81
Milan 77
Woodbridge 72
Wilmington 59
Buffalo 48
The Dalles 47
Los Angeles 40
Florence 36
Tokyo 36
Ho Chi Minh City 35
Princeton 35
Altamura 34
Council Bluffs 34
Dallas 32
New York 32
Bremen 31
Lawrence 31
Munich 31
Lauterbourg 30
Boston 29
Shanghai 29
Hanoi 27
Kent 26
Paris 26
Helsinki 22
Mumbai 22
Boardman 21
Melbourne 21
Rome 20
Medford 18
San Diego 17
Moscow 16
Turku 16
Bern 14
Clifton 14
Redondo Beach 13
Brussels 12
São Paulo 12
Barcelona 11
Johannesburg 11
Chicago 10
London 10
Orem 10
Phoenix 10
Brooklyn 9
Da Nang 9
Toronto 9
Bologna 8
Guangzhou 8
Jakarta 8
Naples 8
Norwich 8
Vienna 8
Abuja 7
Bengaluru 7
Falls Church 7
Frankfurt am Main 7
Jacksonville 7
Stockholm 7
Dong Ket 6
Figino 6
Turin 6
West Jordan 6
Abidjan 5
Ankara 5
Haiphong 5
Lappeenranta 5
Mexico City 5
Norwalk 5
Pune 5
Chennai 4
Fortaleza 4
Hải Dương 4
Palermo 4
Redmond 4
Salt Lake City 4
San Francisco 4
Shenzhen 4
Zurich 4
Baghdad 3
Belo Horizonte 3
Catania 3
Cotonou 3
Hillsboro 3
Izmir 3
Totale 5.038
Nome #
RNA sequencing reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 354
The Inhibitory Effects of HYDAMTIQ, a Novel PARP Inhibitor, on Growth in Human Tumor Cell Lines With Defective DNA Damage Response Pathways. 340
Thymidylate synthase expression and genotype have no major impact on the clinical outcome of colorectal cancer patients treated with 5-fluorouracil 328
Druggable Targets in Pancreatic Adenocarcinoma 310
Selection and characterization of a human ovarian cancer cell line resistant to auranofin 252
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies 248
Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies 248
A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 236
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 227
D13Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 206
THE IMPACT OF GENETIC POLYMORPHISMS ON R-CHOP EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY 203
Identification Of Pharmacogenomic Markers Of Clinical Efficacy In A Dose-Dense Therapy Regimen (R-Chop14) In Diffuse Large B Cell Lymphoma 200
Role of Genetic Polymorphisms on Response to R-CHOP regimen in Diffuse Large B-cell Lymphoma Patients: an Interim Analysis of a Multicenter Prospective Pharmacogenetic Study 196
Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 193
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 190
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 180
Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs 178
PNN and KCNQ1OT1 can predict the efficacy of adjuvant fluoropyrimidine-based chemotherapy in colorectal cancer patients 178
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients 175
Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer 174
Pharmacological modulation of protein kinase C for overcoming drug resistance in colorectal cancer. Preliminary results of in vitro studies. 164
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer 161
Targeting z-Crystallin by aspirin restores the sensitivity to cisplatin in resistant A2780 ovarian cancer cells 157
Marked variation thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression in human colorectal cancer 150
Erratum: The inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on growth in human tumor cell lines with defective DNA damage response pathways (Oncology Research 25:9 (1441-1451) DOI: 10.3727/096504017X14926854178616) 150
Molecular analysis of the FHIT gene in human sporadic colon cancers. 149
Pharmacogenomic Markers of Clinical Efficacy in a Dose-Dense Therapy Regimen (R-CHOP14) in Diffuse Large B Cell Lymphoma 145
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer 144
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphysms in primary colorectal cancer patients. 143
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients 141
Quantitation of intratumoral thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression by the Polymerase Chain Reaction (PCR): marked variation among human colorectal cancer patients 139
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers 139
Comparative genomic hybridization study of genetic changes associated with 5-fluorouracil resistance in HCT-8 colon cancer cell lines: correlations with the expression profiles 136
Sequence-dependent interactions between oxaliplatin and 5-fluorouracil in human colon carcinoma cell lines 132
Pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B cell lymphoma: preliminary results 129
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 127
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 125
Thymidylate Synthase (TS) mRNA expression and TS gene promoter polymorphism in primary colorectal cancer (CRC) patients (PTS) receiving post-operative fluorouracil (5-FU)-based chemotherapy (CT) 121
Expression of thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) genes by polymerase chain reaction (PCR) in gastric cancer patients (PTS): preliminary results 117
Preliminary results of thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression analysis by polymerase chain reaction (PCR) in gastric cancer patients (PTS) 91
The role of thymidylate synthase (TS) expression in prognosis and outcome of 5-fluorouracil (5-FU)-based chemotherapy in patients (pts) with colorectal cancer (CC) 83
Totale 7.459
Categoria #
all - tutte 19.382
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.382


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 0 0 0 0 0 23
2021/2022242 6 22 11 13 7 16 6 26 15 12 39 69
2022/2023818 59 128 40 80 63 140 105 49 104 3 18 29
2023/2024335 7 26 43 10 18 48 30 88 6 15 33 11
2024/20252.146 68 189 132 365 592 340 27 107 84 67 92 83
2025/20262.420 331 313 208 173 309 73 282 95 153 165 77 241
Totale 7.459